 Suzhou Refine Pharmatech Co.,Ltd. Was established on November 12,2019 and is located in Taicang Science and Technology Pioneer Park,Suzhou City,Jiangsu Province. Refine Pharmatech is a professional company dedicating in research and development,production and marketing of pharmaceutical intermediates and API.
Fefine Pharmatech is taking the leading position in technology research and development, with high technology content of pharmaceutical intermediates/chiral compounds, on the basis of the development and production of active pharmaceutical ingredients(APIs) for end products, with industrialization as the ultimate goal, building chiral synthesis,chemical/enzyme catalysis, core technology of clean production process.
Since its establishment in November 2019, Refine Pharmatech has obtained more than 10 computer copyright certificates, such as “Research Platform for the System for Small Molecule Targeted Drugs in the Treatment of Advanced Non-Small Cell Lung Cancer”.Refine Pharmatech has been selected as “Gusu Science and Technology Entrepreneurship Angel Plan” and “Jiangsu Suzhou High-tech Enterprise Cultivation and Storage” enterprises,and is now applying for “National High-tech Enterprise”.
Refine Pharmatech has set up a number of industrialization bases in Sichuan Province,Hebei Province, Anhui Province, with all-weather production capacity of pilot production and commercial production; Refing Pharmatech`s cGMP production facilities can accept FDA, PMDA and other foreign official audit.
Refing Pharmatech has achieved commercial production&sales of products including:Dobutamine、Tadalafil,etc.Innovative process technology research projects include:Migraine preventive drug-Atogepant(MK-8031,AGN-241689), Anti-HIV Agents-Dolutegravir sodium, Antimicrobial drug——Clinafloxacin、Antofloxacin, Antineoplastic agents——Brigatinib、Mitoxantrone,etc. |
News